Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer
Abstract Transurethral resection of bladder tumor (TUR-BT) and radical cystectomy (RC) are standard treatment options for bladder cancer (BC). Neoadjuvant chemotherapy (NAC) prior to RC improves outcome of some patients but currently there are no valid biomarkers to identify patients who benefit fro...
Guardado en:
Autores principales: | Matias Blomqvist, Ilmari Koskinen, Eliisa Löyttyniemi, Tuomas Mirtti, Peter J. Boström, Pekka Taimen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a983ad99b731480d86231b5faa38df2f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer
por: Minna Tervahartiala, et al.
Publicado: (2017) -
Biological Functions and Prognostic Value of Ferroptosis-Related Genes in Bladder Cancer
por: Kezhen Yi, et al.
Publicado: (2021) -
Prognostic value of prostate volume in non-muscle invasive bladder cancer
por: Won Sik Ham, et al.
Publicado: (2021) -
Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Yu Li, et al.
Publicado: (2021) -
Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis.
por: Hui Jiang, et al.
Publicado: (2021)